Viewing Study NCT03181932


Ignite Creation Date: 2025-12-24 @ 9:42 PM
Ignite Modification Date: 2026-01-02 @ 12:58 PM
Study NCT ID: NCT03181932
Status: COMPLETED
Last Update Posted: 2022-12-16
First Post: 2017-06-01
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: AeroVanc in the Treatment of Methicillin-resistant Staphylococcus Aureus Infection in Patients With Cystic Fibrosis
Sponsor: Savara Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2017-09-20
Start Date Type: ACTUAL
Primary Completion Date: 2020-07-28
Primary Completion Date Type: ACTUAL
Completion Date: 2021-01-15
Completion Date Type: ACTUAL
First Submit Date: 2017-06-01
First Submit QC Date: None
Study First Post Date: 2017-06-09
Study First Post Date Type: ACTUAL
Results First Submit Date: 2021-09-02
Results First Submit QC Date: None
Results First Post Date: 2021-11-05
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-12-14
Last Update Post Date: 2022-12-16
Last Update Post Date Type: ACTUAL